ReviewRSC advances2026
Towards hybrid MOF@COF and COF@MOF platforms for next-generation biocatalysis.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enzyme immobilization is central to advancing sustainable biocatalysis, yet conventional supports often fail to simultaneously provide structural protection, mass transport, and chemical tunability. Traditional support materials often lack the optimal combination of porosity, stability, and surface functionality needed to preserve enzyme activity. Metal-organic frameworks (MOFs) and covalent organic frameworks (COFs) have emerged as promising hosts due to their high surface area, tunable porosity, and chemical versatility. Recent developments in hybrid architectures MOF@COF and COF@MOF offer a synergistic platform that integrates the structural flexibility and catalytic tunability of MOFs with the robustness and stability of COFs. This review highlights the design principles, immobilization strategies, and catalytic behavior of enzyme@MOF@COF and enzyme@COF@MOF systems. We discuss advances
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.